Coli 1993.
Study characteristics | ||
Methods | Study design: parallel‐group randomized controlled trial Sample size: 50 Country: Italy Setting: secondary care Dates conducted: not reported Postoperative opioid used and delivery: buprenorphine Pain score collection: not included as outcome Concurrent postoperative analgesics: none reported |
|
Participants |
Inclusion criteria
Exclusion criteria
|
|
Interventions |
Group I (25 participants): IV sodium naproxen 550 mg immediately after induction of anaesthesia Group II (25 participants): IV sodium naproxen 550 mg at the end of surgery |
|
Outcomes |
|
|
Notes | Funding: not reported Declarations of interest: not reported Authors contacted: no Other: article in Italian so translated. Buprenorphine consumption converted to mg intravenous morphine. Standard deviations estimated. Time to analgesic request data extracted from graph |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No details |
Allocation concealment (selection bias) | Unclear risk | No mention |
Blinding of participants and personnel (performance bias) All outcomes | High risk | No double‐dummy placebo. Quote: "group I received Naproxen sodium 550 mg intravenously immediately after induction of anesthesia; group II received sodium naproxen 550 mg intravenously at the beginning of the surgical suture". |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No mention |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All participants analysed |
Selective reporting (reporting bias) | Unclear risk | No protocol or trial registration |
Other bias | Low risk | Similar baseline characteristics. Quote: "The three groups were comparative to the distribution by age, weight, sex and duration of the intervention". |